Highly Potent API (HPAPI) requires specialized equipment in addition to expertise in the handling of potent substances. Between two sites located in Campoverde, Italy and Sligo, Ireland. AbbVie CMO has the capability of producing your HPAPI with containment capabilities up to OEB5 (<0.1 µg/m3). These sites have more than 20 years of experience and can support a broad range of commercial GMP batch sizes including from gram scale up to 600kg. Additionally, both sites are setup with oral solid dosage (OSD) manufacturing capabilities as well and can be your end-to-end supplier.